Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

NCT05799378 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Hydroxychloroquine
DRUG: Placebo

Sponsor

NYU Langone Health

Collaborators

National Institutes of Health (NIH)